Our Mission
Is to eliminate Tuberculosis (TB) globally by supporting research into shorter, safer, affordable, and more effective treatment regimens ensuring accessible care for all.
TB is the archetypal poverty related disease. Yet it is preventable and curable disease, and kills over 1 million people every year.
Treatment is long and difficult to complete, lasting for over 6 months, patients tend to abandon treatment around 3 months, relapse and the disease returns. By making treatment much shorter, we can save more lives and reduce the strain on global health systems.
Our Impact
Supported Global
Research
We have contributed to clinical trials exploring how TB treatment can be shortened from 6 to 2 months - aiming to improve outcomes and reduce burden on patients.
Built International Partnerships
We collaborate with healthcare professionals and researchers globally, including in high disease areas across Africa, Asia, and Eastern Europe to strengthen TB care and research capacity.
Directed Funding To Frontline Work
Since 2007 we have raised funds through donations and continue to require funding to supporting project delivery, including training, equipment, and trial facilitation.
Our Roots in TB Innovation
Dr Amina Jandani -
World Without Tuberculosis was founded in 2007 by Professor Amina Jindani, a trained medic and globally respected TB researcher whose work has shaped modern treatment. She has dedicated her entire academic life, to leading landmark international clinical trials, including the RIFAQUIN, RIFATOX and RIFASHORT studies, and helping pioneer the 6-month treatment regimen still used today. Her research has directly influenced the World Health Organization (WHO) policy and strengthened TB programs across Africa, Asia, and beyond.
Dr. Jindani continues to contribute her expertise and support the fight against TB - still working toward her objective of reducing treatment duration to 3 and possibly less months.